Target intelligence / Profile preview

Autophagy pathway regulation in renal tissue

Molecular classification
Other
01

Overview

Autophagy pathway regulation in renal tissue refers to the complex network of signaling mechanisms that control the degradation and recycling of intracellular components for cellular quality control and adaptation to stress, particularly in kidney cells. Key regulators include mTOR, AMPK, and FXR, modulating the activity of multiple autophagy-related proteins (ATG proteins, Beclin-1, LC3) in response to injury, metabolic cues, or pharmacological agents. Dysregulation of autophagy plays a vital role in the pathogenesis and progression of kidney diseases including acute kidney injury, chronic kidney disease, and renal fibrosis. However, "autophagy pathway regulation in renal tissue" is not a singular druggable target but a process involving several pathways and molecules.

Other names
Autophagy in the kidneyRenal autophagy regulationAutophagy pathway in renal tissue
02

Mechanism of action

Induction or inhibition of autophagy via signaling pathways (e.g., mTOR, AMPK, FXR)

03

Biological functions

Cellular homeostasisOrganelle quality controlCell survivalCell death (apoptosis, regulated necrosis)Metabolic adaptationInflammation modulation
04

Disease associations

Acute kidney injuryChronic kidney diseaseRenal fibrosisDiabetic nephropathy
05

Safety considerations

Overactivation or blockade of autophagy may induce unwanted cell death or fibrosisNonspecific targeting may disrupt cellular homeostasis
06

Interacting drugs

Rapamycin (mTOR inhibitor, autophagy inducer)

2 more in the full profile.

07

Biomarkers

Beclin-1 (BECN1)LC3-II/LC3-I ratiop62/SQSTM1ATG proteins (e.g., ATG7, ATG3)

Beyond the preview

Go deeper on Autophagy pathway regulation in renal tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy pathway regulation in renal tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call